TIAP and Evotec Expand LAB150 BRIDGE Partnership to Include Amgen
Amgen to Join LAB150 to Build Canada’s Next Generation of Life Science Companies TORONTO, Canada & HAMBURG, Germany–(BUSINESS WIRE)–#LifeSciences–Toronto Innovation Acceleration Partners (“TIAP”) and Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) today announced that the two companies have expanded LAB150, their translational BRIDGE partnership, to include Amgen as a strategic partner. … [Read more…]
